ASAM Pocket Guidelines and Patient Guide

Stimulant Use Disorder

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1519511

Contents of this Issue

Navigation

Page 21 of 29

22 Treatment Table 2. Medications for Managing Intoxication a Agent/Class Mechanism Example dosing Sedatives Benzodiazepines (BZDs) (first line) GABAergic Initial dosing : Lorazepam 1–2 mg intravenous (IV) based on clinical signs and symptoms and duration of effects Diazepam 5–10 mg per os (by mouth/ oral) (PO) for less severe symptoms based on patient parameters Midazolam 5 mg intramuscular (IM) or 0.01–0.05 mg/kg IV for acute agitation in adult patients Redosing frequency and dose should be guided by the degree and duration of the clinical effects of the initial dose Phenobarbital (PBO) GABAergic Incremental 130–260 mg IM/IV/ PO based on symptoms and patient parameters Loading strateg y (eg, 5–10 mg/kg ) Titrate based on clinical effects Propofol GABAergic + N-methyl- D-aspartate (NMDA) receptor antagonism 10–50 μg/kg/min based on symptoms and patient parameters Sympatholytics Clonidine Alpha-2 agonism +/– other 0.1–0.2 mg PO every 4 hours as needed Dexmedetomidine Alpha-2 agonism Start at 0.2–0.4 μg/kg/hr and titrate every 30 min up to maximum of 1.5 μg/kg/hr

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Stimulant Use Disorder